Clinical Trial Update: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atamestane plus toremifene versus letrozole in advanced breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atamestane (atamestane)
• FARESTON (toremifene citrate)
• FEMARA (letrozole)

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent | Phase 3 | Status: TERMINATED